Alterations in VGCC expression levels and functionality are associated with several pathophysiological processes, such as epilepsy [12, 13], but this is the first time changes in CACNB3 expression have been associated with drug-resistant epilepsy in humans. The gene discussed is CACNB3; the disease is epilepsy.